Which of the following tests aspartate aminotransferase, alanine transaminase and alkaline phosphatase, can predict poor outcomes in Coronavirus 2019 patients? a retrospective cohort study

Background:Coronavirus 2019 (COVID-19) disease caused a recent pandemic that killed thousands of people by causing mild and severe systemic organ involvement. Researchers are still trying to find the proper diagnosis tool for the disease. In addition, we investigated the effect of aspartate aminotra...

Full description

Saved in:
Bibliographic Details
Main Authors: Pouyan Ebrahimi, AmirHossein Nasiri-Valikboni, Mahmoud Sadeghi Haddad Zavareh, Hoda Shirafkan, Seyed Hassan Abedi
Format: Article
Language:English
Published: Kerman University of Medical Sciences 2024-05-01
Series:Journal of Kerman University of Medical Sciences
Subjects:
Online Access:https://jkmu.kmu.ac.ir/article_92371_a429367cf4be42b68dc4cabe7c5330f4.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849774483527696384
author Pouyan Ebrahimi
AmirHossein Nasiri-Valikboni
Mahmoud Sadeghi Haddad Zavareh
Hoda Shirafkan
Seyed Hassan Abedi
author_facet Pouyan Ebrahimi
AmirHossein Nasiri-Valikboni
Mahmoud Sadeghi Haddad Zavareh
Hoda Shirafkan
Seyed Hassan Abedi
author_sort Pouyan Ebrahimi
collection DOAJ
description Background:Coronavirus 2019 (COVID-19) disease caused a recent pandemic that killed thousands of people by causing mild and severe systemic organ involvement. Researchers are still trying to find the proper diagnosis tool for the disease. In addition, we investigated the effect of aspartate aminotransferase (AST), alanine transaminase (ALT), and alkaline phosphatase (ALP) enzymes on long-term outcomes.Methods:The variables in this retrospective cohort study were collected from the records of patients with Covid-19 referred to Rouhani Hospital in Mazandaran, northern Iran. Patients were followed up to the cut-off points for mortality.Results:Among 320 eligible patients, AST levels, unlike ALT and ALP, were significantly associated with mortality (p<0.001) and disease severity (p=0.016). The level of AST, unlike the level of other tests examined at the time of referral, has a significant effect on mortality at admission time (p < 0.001, 95% CI= 2.433 to 20.463, MD = 7.056) and time of admission to the intensive care unit (ICU) (P = 0.012, 95% CI= 1.291 to 7.907, MD = 3.195). None of the tests (AST, ALT and ALP) could predict long-term mortality in patients.Conclusions:AST levels, unlike ALP and ALT levels, have shown an excellent ability to predict mortality and severity at admission, but neither of AST, ALT and ALP predicted long-term adverse outcomes.
format Article
id doaj-art-d0c9f9d5e2f3437690fd1dd9be3395e5
institution DOAJ
issn 1023-9510
2008-2843
language English
publishDate 2024-05-01
publisher Kerman University of Medical Sciences
record_format Article
series Journal of Kerman University of Medical Sciences
spelling doaj-art-d0c9f9d5e2f3437690fd1dd9be3395e52025-08-20T03:01:41ZengKerman University of Medical SciencesJournal of Kerman University of Medical Sciences1023-95102008-28432024-05-013129810392371Which of the following tests aspartate aminotransferase, alanine transaminase and alkaline phosphatase, can predict poor outcomes in Coronavirus 2019 patients? a retrospective cohort studyPouyan Ebrahimi0AmirHossein Nasiri-Valikboni1Mahmoud Sadeghi Haddad Zavareh2Hoda Shirafkan3Seyed Hassan Abedi4student Committee Research, Babol University of Medical Science, Babol, Iranstudent Committee Research, Babol University of Medical Science, Babol, IranInfectious Diseases and Tropical Medicine Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, IranSocial Determinants of Health Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, IranDepartment of Internal Medicine, School of Medicine, Babol University of Medical Sciences, Babol, I.R IranBackground:Coronavirus 2019 (COVID-19) disease caused a recent pandemic that killed thousands of people by causing mild and severe systemic organ involvement. Researchers are still trying to find the proper diagnosis tool for the disease. In addition, we investigated the effect of aspartate aminotransferase (AST), alanine transaminase (ALT), and alkaline phosphatase (ALP) enzymes on long-term outcomes.Methods:The variables in this retrospective cohort study were collected from the records of patients with Covid-19 referred to Rouhani Hospital in Mazandaran, northern Iran. Patients were followed up to the cut-off points for mortality.Results:Among 320 eligible patients, AST levels, unlike ALT and ALP, were significantly associated with mortality (p<0.001) and disease severity (p=0.016). The level of AST, unlike the level of other tests examined at the time of referral, has a significant effect on mortality at admission time (p < 0.001, 95% CI= 2.433 to 20.463, MD = 7.056) and time of admission to the intensive care unit (ICU) (P = 0.012, 95% CI= 1.291 to 7.907, MD = 3.195). None of the tests (AST, ALT and ALP) could predict long-term mortality in patients.Conclusions:AST levels, unlike ALP and ALT levels, have shown an excellent ability to predict mortality and severity at admission, but neither of AST, ALT and ALP predicted long-term adverse outcomes.https://jkmu.kmu.ac.ir/article_92371_a429367cf4be42b68dc4cabe7c5330f4.pdfcovid-19aspartate aminotransferasealkaline phosphatasealanine transaminase
spellingShingle Pouyan Ebrahimi
AmirHossein Nasiri-Valikboni
Mahmoud Sadeghi Haddad Zavareh
Hoda Shirafkan
Seyed Hassan Abedi
Which of the following tests aspartate aminotransferase, alanine transaminase and alkaline phosphatase, can predict poor outcomes in Coronavirus 2019 patients? a retrospective cohort study
Journal of Kerman University of Medical Sciences
covid-19
aspartate aminotransferase
alkaline phosphatase
alanine transaminase
title Which of the following tests aspartate aminotransferase, alanine transaminase and alkaline phosphatase, can predict poor outcomes in Coronavirus 2019 patients? a retrospective cohort study
title_full Which of the following tests aspartate aminotransferase, alanine transaminase and alkaline phosphatase, can predict poor outcomes in Coronavirus 2019 patients? a retrospective cohort study
title_fullStr Which of the following tests aspartate aminotransferase, alanine transaminase and alkaline phosphatase, can predict poor outcomes in Coronavirus 2019 patients? a retrospective cohort study
title_full_unstemmed Which of the following tests aspartate aminotransferase, alanine transaminase and alkaline phosphatase, can predict poor outcomes in Coronavirus 2019 patients? a retrospective cohort study
title_short Which of the following tests aspartate aminotransferase, alanine transaminase and alkaline phosphatase, can predict poor outcomes in Coronavirus 2019 patients? a retrospective cohort study
title_sort which of the following tests aspartate aminotransferase alanine transaminase and alkaline phosphatase can predict poor outcomes in coronavirus 2019 patients a retrospective cohort study
topic covid-19
aspartate aminotransferase
alkaline phosphatase
alanine transaminase
url https://jkmu.kmu.ac.ir/article_92371_a429367cf4be42b68dc4cabe7c5330f4.pdf
work_keys_str_mv AT pouyanebrahimi whichofthefollowingtestsaspartateaminotransferasealaninetransaminaseandalkalinephosphatasecanpredictpooroutcomesincoronavirus2019patientsaretrospectivecohortstudy
AT amirhosseinnasirivalikboni whichofthefollowingtestsaspartateaminotransferasealaninetransaminaseandalkalinephosphatasecanpredictpooroutcomesincoronavirus2019patientsaretrospectivecohortstudy
AT mahmoudsadeghihaddadzavareh whichofthefollowingtestsaspartateaminotransferasealaninetransaminaseandalkalinephosphatasecanpredictpooroutcomesincoronavirus2019patientsaretrospectivecohortstudy
AT hodashirafkan whichofthefollowingtestsaspartateaminotransferasealaninetransaminaseandalkalinephosphatasecanpredictpooroutcomesincoronavirus2019patientsaretrospectivecohortstudy
AT seyedhassanabedi whichofthefollowingtestsaspartateaminotransferasealaninetransaminaseandalkalinephosphatasecanpredictpooroutcomesincoronavirus2019patientsaretrospectivecohortstudy